Trial Profile
Safety of Remdesivir Treatment in COVID-19 Patients Requiring Hemodialysis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2022
Price :
$35
*
At a glance
- Drugs Remdesivir (Primary)
- Indications COVID-19 pneumonia
- Focus Adverse reactions
- Acronyms REM-HD
- 08 Nov 2022 Status changed from recruiting to completed.
- 03 Mar 2022 Planned End Date changed from 1 Nov 2021 to 1 Jul 2022.
- 03 Mar 2022 Planned primary completion date changed from 1 Oct 2021 to 1 Jul 2022.